
Intus Bio: Powering a microbiome revolution with high-resolution data for improved patient safety and healthcare outcomes.
intusbio.comCrawled Oct 16, 2026
Intus Biosciences accepts inquiries about research collaboration, clinical testing, and media requests.
Powering precision health through microbiome innovation. Titan-1 delivers strain-level resolution for research, clinical testing, and personalized wellness.
Intus Bio’s privacy policy explains how it collects, uses, and protects information and outlines users’ rights when using its website.
The company’s terms and conditions explain how it collects, uses, and handles information when people access or interact with its website.
Intus Bio secures a **$2.7 million grant from the National Cancer Institute (NCI)** to advance a **noninvasive microbiome-based test** for early colorectal cancer (CRC) and precancerous lesions. The test identifies bacterial biomarkers in stool samples to detect disease at earlier stages. The project leverages microbiome research to improve early diagnosis in high-risk populations.
Sep 2026genomeweb.comNews article
Intus Bio leads a consortium of four research institutions to develop a non-invasive early-onset colorectal cancer screening test using bacterial microbiome analysis. The project secures a **$2.7 million NIH/NCI Fast-Track Award**, accelerating research into high-resolution bacterial markers for detection. The test aims to provide an alternative to invasive screening methods by leveraging microbiome discoveries.
Sep 2026PR NewswireNews article
Gutid offers a $599 at-home test analyzing stool samples to assess gut health. Research shows two-thirds of U.S. adults experience chronic digestive issues like gas and bloating, yet many avoid medical consultation. The test aims to provide insights into gut microbiome composition without requiring a doctor’s visit.
Apr 2025New York PostNews article
PacBio and Intus Bio introduce **GutID**, the first at-home microbiome test using **HiFi sequencing** and **Intus Bio’s Titan-1 platform**. The test combines **strain-level microbial resolution** with **AI-driven analysis** to deliver gut health insights. PacBio’s sequencing technology ensures high accuracy for clinical-grade results.
Jan 2025Yahoo FinanceNews article